Ken Griffin’s Myovant Sciences Ltd. MYOV Stock Holding History

Ken Griffin’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,900	Closed	-$429K	–	16060
2022 Q4	$429K	Sell	15,900 -118,100	-88%	-$3.11M	﹤0.01%	8562
2022 Q3	$2.41M	Sell	134,000 -118,800	-47%	-$1.9M	﹤0.01%	5232
2022 Q2	$3.14M	Buy	252,800 +122,800	+94%	+$1.36M	﹤0.01%	4676
2022 Q1	$1.73M	Buy	130,000 +30,700	+31%	+$412K	﹤0.01%	6411
2021 Q4	$1.55M	Buy	99,300 +17,700	+22%	+$338K	﹤0.01%	6823
2021 Q3	$1.83M	Sell	81,600 -8,700	-10%	-$191K	﹤0.01%	6584
2021 Q2	$2.06M	Sell	90,300 -2,900	-3%	-$61K	﹤0.01%	6557
2021 Q1	$1.92M	Sell	93,200 -6,900	-7%	-$157K	﹤0.01%	6481
2020 Q4	$2.77M	Buy	100,100 +3,300	+3%	+$64.2K	﹤0.01%	4714
2020 Q3	$1.36M	Sell	96,800 -6,900	-7%	-$128K	﹤0.01%	5456
2020 Q2	$2.14M	Buy	103,700 +82,600	+391%	+$1.12M	﹤0.01%	4455
2020 Q1	$159K	Sell	21,100 -18,100	-46%	-$203K	﹤0.01%	8238
2019 Q4	$608K	Buy	+39,200	New	+$395K	﹤0.01%	6489

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Ken Griffin's MYOV Position: Q1 2023 in Review

Ken Griffin sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 100,059 shares — an estimated $2.7M sold.

Ken Griffin first reported a position in MYOV in Q2 2019 and held it in 15 quarters. The position peaked at $17.4M in Q3 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Ken Griffin reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Ken Griffin sold 100,059 Myovant Sciences Ltd. shares in Q1 2023, an estimated $2.7M.
Ken Griffin first reported a position in Myovant Sciences Ltd. in Q2 2019 and held it in 15 quarters.
Ken Griffin's Myovant Sciences Ltd. position peaked at $17.4M in Q3 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.